Related Experiment Video
Updated: Aug 24, 2026

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
Bradycardia induced by hyperkalemia
Karen Vuckovic1, Danielle Richlin
1University of Illinois at Chicago College of Nursing, USA.
Insights
Occupational health nurses must recognize risks of hyperkalemia in patients with cardiac conditions. Current treatments for myocardial ischemia and left ventricular dysfunction can elevate potassium levels, particularly with kidney issues.
Area of Science:
- Cardiology
- Occupational Health Nursing
Background:
- Rising incidence of chronic cardiac disease necessitates awareness of treatment complications.
- Occupational health nurses play a crucial role in monitoring patient safety.
Observation:
- Current treatment guidelines for myocardial ischemia and left ventricular dysfunction pose risks.
- Combination therapy with ACE inhibitors and potassium-sparing diuretics is common.
Findings:
- This treatment regimen increases the risk of hyperkalemia (elevated potassium).
- Renal insufficiency significantly exacerbates the risk of hyperkalemia.
Implications:
- Nurses must be vigilant for adverse effects like electrolyte abnormalities.
- Early recognition and management of hyperkalemia are critical for patient outcomes.
- Case studies highlight the importance of understanding drug interactions and patient comorbidities.
Abstract:
The incidence of chronic cardiac disease is increasing (Jessup, 2003). As a result, it is important for occupational health nurses to recognize adverse effects (e.g., electrolyte abnormalities, dysrhythmias) associated with current treatment guidelines (Hunt, 2001). As shown in the example in this case study, the current recommended treatment for clients who have myocardial ischemia and left ventricular dysfunction (i.e., ACE inhibitor and a potassium-sparing diuretic) puts clients at risk for hyperkalemia, especially in the presence of renal insufficiency.
Related Concept Videos
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with bradycardia...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism, and...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

